On March 9, 2026, enGene Holdings Inc. entered into a sales agreement with Leerink Partners to potentially sell up to $100 million of its common shares. Additionally, the previous sales agreement with Jefferies LLC was terminated effective March 6, 2026, with no shares sold under it.